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Herbal medicine (HM) is a part of future alternative health care. According to the World 
Health Organization (WHO), almost 70-80% of the population of developing countries 
rely on HM as an immediate need for health services, one of which is the Asian region. 
With the high trend of a healthy lifestyle using natural ingredients, drug safety must be a 
significant concern. This review article aims to provide information on studying the toxicity 
of Asian herbal plants to hepatotoxic and nephrotoxic activities. The research method 
was conducted by searching using the keywords “Herbal Medicine(HM),” “Efficacy,” 
“Nephrotoxicity,” “Hepatotoxicity,” “Asia,” “extract” on the Google site and Google 
Scholar. The primary data sources used consisted of national journals, international 
journals, and the WHO website. Articles were screened using the inclusion criteria of 
Indonesian and English journals published in the last ten years. Of the toxicity study 
articles discussing 10 herbs-induced liver injury (HILI) and 10 drug-induced liver injury 
(DILI) that we reviewed, it is known that the dose consumed has a more significant effect 
on the incidence of hepatotoxicity and nephrotoxicity than the duration of administration 
with low doses. However, the period of administration with high doses has a significant 
relationship with liver and kidney damage. Therefore, disseminating safety studies to the 
public is very important to maximize drug efficacy and avoid hepatotoxicity and 
nephrotoxicity. 
 





Herbal medicine (HM) is part of alternative health care in the future.1 According to 
the World Health Organization (WHO), 60% of the world's population depends on HM. 
Almost 70-80% of the people from developing countries rely on HM as an immediate 
need for health care.2 One of the continents with the most significant number of 
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quantity and 45% of global revenue from traditional medicines. Two countries that play 
a significant role in this are China and India.4 Data from the Southeast Asian Institute of 
Thai-Chinese Medicine in 2010 showed that less than 1% of the population used 
acupuncture and 1–19% used Chinese HM. The absence of confidence in the side risks 
associated with synthetic drugs makes the use of HM much in demand 5, mainly because 
of their secondary metabolite content.6 
Secondary metabolites in plants have been shown to possess pharmacological 
activity to treat chronic and acute diseases, especially preventive therapy.7 With 
increasing healthy lifestyles using natural ingredients, drug safety should focus on 
attention apart from its efficacy effects.8 Safety is closely related to the quality control of 
HM.9 However, the limitations of scientific studies on evidence of efficacy and safety 
make HM still sceptical in the medical community. The lack of information regarding the 
safety of using HM in the general public is feared to be consumed more than the 
prescribed safe dose. This will be very dangerous considering the presence of 
nephrotoxic phytochemical compounds such as aristolochic acid and alkaloids.10,11 
Paracelsus (Father of Toxicology) said in German, “Alle Dinge sind Gift und nichts ist 
ohne Gift, allein die Dosage machine, dass ein Ding kein Gift ist,” which means 
“Everything is poison and nothing is without poison. Only the dose determines that 
something is non-toxic”.12 Therefore, this review article systematically discusses the use 
of plant extracts in therapy and their dosage, the mechanism of nephrotoxicity, and 




The search was conducted using the keywords “Herbal Medicine,” “Safety,” 
“Nephrotoxicity,” “Hepatotoxicity,” “Asia,” “extract” through the Google site and 
GoogleScholar. The primary data sources used consisted of national journals, 
international journals, and the WHO website. Articles were filtered with the inclusion 
criteria of accredited Indonesian and English journals focusing on hepatotoxic and 





Table 1. Effect of Hepatotoxicity by Herbal Extracts 
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Table 2. Effect of Nephrotoxicity by Herbal Extracts 




















LD50 = ≥ 50 
mg/kg i.p. has 
been observed 














































LD50 = ≥  140 
mg/kg i.p. has 
been observed 






















LD50 = ≥ 600 
















albino rats)  
LD50 
(subchronic 
toxicity) =  ≥ 2,5 
g/kg p.o. has 
been observed 
for three weeks 
showed mild 
tubular atrophy; 







Jurnal Ilmiah Farmako Bahari 
Vol. 12; No. 2; Juli 2021 
Halaman 169-182 














test. (in F344 
mice)  
LD50 = ≥ 2000 























LD 50 =  ≥ 1000 
mg/kg p.o. has 
been observed 
















Dawley rats)  
• LD50 (acute 






















LD50 = ≥ 400 




























toxicity test.  
















Jurnal Ilmiah Farmako Bahari 
Vol. 12; No. 2; Juli 2021 
Halaman 169-182 





E-ISSN: 2715-9949      
Discussion 
 
Prevalence of Herbal Medicines Use in Asia 
The use of HM in Asia and Indonesia is estimated to increase over the years. In some 
Asian and African countries, about 80% of the rural population depends on traditional 
medicine for primary health care.36 China and India are the Asian countries that play the 
most role in the development of HM. India has played an essential part for thousands of 
years in managing medicinal plants as alternative therapies.37 In 2016, a study in 32 
primarily high-income countries stated that the prevalence rate of traditional therapy use 
over the past 12 months averaged 26.4%, ranging from less than 10% in some Eastern 
European countries to more than 50% in China, South Korea, and the Philippines.38 In 
ASEAN, the highest use of herbal therapy was in Malaysia (55.6%), Singapore (among 
older adults) (42.7%), the Philippines (6.3%), Cambodia (5.4%), Vietnam (3.5%), 
Thailand (2.6%) and Indonesia (2.0%).39 In Indonesia, based on an extensive national 
household survey in 2013, 30.4% of families used traditional medicine for health care.40 
The current use of conventional medicine is generally only found in patients with cancer 
or malignant tumors (14.4%), followed by arthritis/rheumatism (11.3%), high cholesterol 
(11.3%), stroke (10.2%), diabetes (9.9%), kidney disease (9.7%), liver disease (8.0%), 
hypertension (7.2%), and memory-related diseases (6.8%).41 
 
Mechanism of Hepatotoxicity  
The liver is part of the human organ that is very sensitive to injury due to its vital role 
in neutralizing toxins.42 Therefore, excessive exposure to toxins from food, beverages, 
drugs (synthetic and non-synthetic (HM)) has the potential to cause liver injury 
(hepatotoxicity).43 Hepatotoxicity induced by irregular drug use is commonly known as 
DILI (Drug-Induced Liver Injury).44 Hepatotoxicity due to HM is commonly known as HILI 
(Herb-Induced Liver Injury).45 
HILI is liver damage which is one of the causes is triggered by the use of plants with 
unknown toxicity limits.46 The mechanism of HILI is divided into three stages, starting 
from early liver cell damage through direct cell stress, mitochondrial suppression, and/or 
specific immune response. Following the mitochondrial permeability transition (MPT) 
stage, early injury can induce MPT, and cellular stress directly induces MPT via internal 
pathways. The last stage is hepatocyte death; MPT can cause necrosis or apoptosis 
depending on ATP defense availability, and regeneration abilities can restore the 
damaged liver cells. Any action taken involves various environmental and genetic 
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The level of hepatotoxicity caused by HILI is classified into three types, including 
hepatocellular, cholestatic, and mixed.45 These were classified according to the value of 
the R ratio obtained by comparing the results of the initial measurement of alanine 
aminotransferase (ALT) with alkaline phosphatase (ALP) using multiples of the upper 
limit of the normal range for both values. R ≥ 5 indicates hepatocellular liver injury; R ≤ 2 
is cholestatic; and  2 < R < 5 is mixed.49,50 There are two critical factors for HILI 
development, including the level of drug exposure (dose) and the adaptive immune 
response. Drug exposure and the nature of the drug administered play a significant role 
in the early stages of cell damage. Once damaged, both innate and adaptive responses 
emerge and play an essential role in triggering inflammation and tissue injury.47 
 
Mechanism of Nephrotoxicity  
Kidneys are part of the functional unit of the body, containing about 1 million 
nephrons, one of which functions play an essential role in neutralizing drug toxicity. The 
loss of one or more cells in the nephron can cause functional kidney damage.51 The term 
nephron damage due to exogenous drugs/toxins is known as nephrotoxicity.52 
Nephrotoxicity has a relationship with the use of HM. The use of HM that has been 
shown to cause nephrotoxicity directs their toxic effects through one or more pathogenic 
mechanisms.53 There are different mechanisms of nephrotoxicity, including renal tubular 
toxicity, inflammation, glomerular damage, crystal nephropathy, and thrombotic 
microangiopathy. Toxic substances and drugs induce oxidative stress that causes 
damage to the renal tubules, thereby causing potential damage to the renal tubular 
transport system.54 This oxidative stress arises due to the presence of lipopolysaccharide 
(LPS), which activates NF-B and mitogen-activated protein kinases (MAPKs).55  
One well-known example of nephrotoxicity due to HM is triggered by aristolochic 
acid.56 Aristolochic acid (AA) is a group of nitrophenanthrene carboxylic acid compounds 
found in the Aristolochiaceae plant family, consisting of aristolochic acid I (AAI) and 
aristolochic acid II (AAII), which are distinguished by the presence of an O-methoxy 
group at position 8 for AAI while AAII does not have an O-methoxy group at position 8 









Figure 2. Chemical Structure of AAI (left) and AAII (right) 58 
 
Based on research, AA has been associated with the induction of oxidative stress 
(ROS) and apoptosis.59 Exposure to AAI in the proximal renal tubule that enters through 
OAT1/OAT3(organic anion transporter 1/organic anion transporter 3) induces ROS that 
can cause DNA damage (TP53, OGG1), induce ER(endoplasmic reticulum) and 
mitochondrial stress, or activate the MAPK(mitogen-activated protein kinase) pathway.60 
ER induction causes an increase in Ca2+, which causes the mitochondria to release 
cytochrome C (Cyt C). Cyt C activates caspase-3, resulting in apoptosis. Endoplasmic 
reticulum (ER) and AAI-induced mitochondrial stress were also associated with 
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As for the interaction of AAI with MAPK, the induction of apoptosis is related to the 

















Figure 3. Mechanism of Herb Induced Kidney Injury 61 
ROS(reactive oxygen species); CYP1A1(cytochrome P450 family 1 subfamily A member 1); 
CYP1A2(cytochrome P450 family 1 subfamily A member 2); MAPK(mitogen-activated 
protein kinase); Cyt C(cytochrome C); SARA(smad anchor for receptor activation); TGF-
ꞵR1/TGF-ꞵR2 (transforming growth factor-beta receptor 1/ transforming growth factor-beta 
receptor 2); ECM(extracellular matrix); MMP(matrix metalloproteinase); 
MDA(Malondialdehyde); TNFR(tumor necrosis factor receptors); EGFR(epidermal growth 
factor receptor); ERK1/2(extracellular signal regulated kinase ½); Bcl-2(B-cell lymphoma 2); 
ATP (adenosine tri-phosphate); ADP(adenosine diphosphate); SOS(son of sevenless); 
SHC(src homology and containing protein); GRB2 (growth factor receptor-bound protein 2). 
 
Hepatotoxic and Nephrotoxic-Inducing Herbs  
Hepatotoxicity is a severe event of the liver that may cause death if not adequately 
controlled. SGOT, SGPT, and histopathological tests can identify hepatotoxicity.62 
Hepatotoxicity can occur due to accidental contamination with non-herbal drugs causing 
hepatotoxicity (e.g., NSAIDs) or the content of secondary metabolites of some HM.63,64 
Sometimes, hepatotoxicity is also associated with self-medication without medical 
assistance, misdiagnosis, and the presence of comorbid diseases.65–67 The lack of 
information regarding HM toxicity studies may also contribute to hepatotoxicity.68 HM 
consists of unrefined plant parts or plant extracts containing several elements that are 
generally considered to work synergistically.69 The following are examples of several 
plant toxicity studies on hepatotoxicity shown in Table 1. 
Likewise, nephrotoxicity, as well as hepatotoxicity, has a relationship with HM. 
Several herbal plants used in the long term, from the results of toxicity studies, have 
been observed to induce tubular necrosis and atrophy.29 Urea and creatinine levels can 
also observe the glomerular function. However, the histopathological test remains the 
golden standard in identifying nephrotoxicity.70 The following are some examples of plant 
toxicity studies on nephrotoxicity shown in Table. 2. 
Of some of the articles that we have reviewed, it is not entirely safe to use herbal 
remedies. Several herbal plants have hepatotoxicity and nephrotoxicity activity. It is 
known that increasing the dose consumed more affects the incidence of hepatotoxicity 
and nephrotoxicity than the duration of administration with low doses. However, 
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used. Therefore, it is crucial to know the toxic dose of HM use and further research to 




The use of HM is closely related to the dose. Of the results of toxicity studies of 
several plants, it was observed that there was cell degeneration activity that worsened 
the functional conditions of the liver and kidneys with increasing doses. Therefore, 
disseminating information regarding safety studies to the public is very important to 
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